Tiagabine(CAS番号:115103-54-3)

基本情報

Tiagabine

CAS番号

115103-54-3

分子式

C20H25NO2S2

分子量

375.56 g/mol

Quick Actions

基本的な物理特性

融点

192oC dec.

沸点

568°C at 760 mmHg

SMILES

CC1=C(SC=C1)C(=CCCN2CCCC(C2)C(=O)O)C3=C(C=CS3)C

InChI

InChI=1S/C20H25NO2S2/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23)/t16-/m1/s1

InChIKey

PBJUNZJWGZTSKL-MRXNPFEDSA-N

LogP

5.044840000000004

トポロジカル極性表面積

40.540000000000006 Ų

水素結合ドナー/アクセプター

1 / 3

複雑度

474

分類と用途

安全情報

安全情報を表示

危険性の表示

H315-H319-H335

同義語と参考文献

英語

  • GTPL4685
  • Tiagabine [INN:BAN]
  • 1-[4,4-Bis-(3-methyl-4,5-dihydro-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid
  • HY-B0696
  • (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxylic acid
  • BDBM50039251
  • D08588
  • DTXCID503663
  • DTXSID5023663
  • Tiagabinum [INN-Latin]
  • Gabatril
  • NCGC00164626-01
  • N03AG06
  • HSDB 7527
  • TIAGABINE [WHO-DD]
  • C07503
  • Gabitril
  • NO 050328
  • (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid
  • (R)-(-)-1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid
  • 1006863-69-9
  • (R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid
  • (R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enyl)piperidine-3-carboxylic acid hydrochloride
  • (R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enyl)piperidine-3-carboxylic acid
  • NO 328
  • Gabitril (TN)
  • 1-[4,4-Bis-(3-methyl-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid; hydrochloride
  • Tiagabina
  • BDBM50368628
  • (3R)-1-(4,4-BIS(3-METHYL-2-THIENYL)-3-BUTEN-1-YL)-3-PIPERIDINECARBOXYLIC ACID
  • AC-7048
  • s4675
  • NNC-050328 FREE BASE
  • NO-050328 FREE BASE
  • 3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, (3R)-
  • ABBOTT-70569-1
  • (-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid
  • TIAGABINE [MI]
  • (-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3butenyl]nipecotic acid hydrochloride
  • AMY22648
  • CHEBI:9586
  • Z80I64HMNP
  • Tiagabine (INN)
  • TIAGABINE [VANDF]
  • GTPL4818
  • (S)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enyl)piperidine-3-carboxylic acid
  • CHEMBL1027
  • NS00001014
  • NO050328
  • HMS3885J16
  • CCG-268358
  • TIAGABINE [HSDB]
  • PBJUNZJWGZTSKL-MRXNPFEDSA-N
  • (-)-(r)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid
  • 115103-54-3
  • Q907219
  • Tiagabine [INN]
  • (3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid
  • (R)-1-[4,4-Bis-(3-methyl-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid; hydrochloride
  • Tiagabina [INN-Spanish]
  • ABBOTT-705691 FREE BASE
  • NO328
  • (R)-1-(4,4-Bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid
  • (3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxylic acid; Gabitril
  • DB00906
  • [3H]tiagabine
  • (3R)-1-
  • 3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl)-, (3R)-
  • (-)-(R)-1-
  • Abbott-70569
  • (R)-1-[4,4-Bis-(3-methyl-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid
  • BIDD:GT0018
  • Tiagabinum (INN-Latin)
  • EN300-222195
  • (3R)-1-(4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl)piperidine-3-carboxylic acid
  • ABBOTT-70569 FREE BASE
  • tiagabine
  • Tiagabinum
  • (R)-Tiagabine
  • TGB
  • UNII-Z80I64HMNP
  • SCHEMBL34653
  • A-70569-1
  • Tiagabina (INN-Spanish)
  • ABT-569 FREE BASE
  • 3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-, (R)-
  • BRD-K60160658-003-08-8
  • (r)-n-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid
  • AKOS016011165
  • Tiagabine
  • TIAGABINE, HYDROCHLORIDE
  • (R)-(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid
  • (R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid
  • (R)-1-[4,4-bis(3-methyl-thien-2-yl)-3-butenyl]-3-piperidinecarboxylic acid
  • (R)-N-[4,4-di-(3-methylthien-2-yl)but-3-enyl] nipecotic acid hydrochloride
  • 4-bis(3-methyl-2-thienyl)-3-butenyl)-1-((r)-3-piperidinecarboxylicaci
  • NNC 05-328
  • NO-05-0328
  • no328
  • TIGABINE
  • (3R)-1-[4,4-Bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid
  • Tiagabin
  • nnc-05-0328
  • NNC-05-0328:A-70569
  • Gabitril / NNC 05-328
  • Tiagabine 145821-59-6 /

MDL_Number

MFCD00865317

CAS番号

115103-54-3

サプライヤー情報

サプライヤー名 会員レベル 認証状況 主要カテゴリー 最小注文数量 アクション
中国中国 - Shanghai Mofu Medicine Technology Co., Ltd.
中国中国 - Hangzhou Yaorieyicheng Biopharmaceutical Co., Ltd.
中国中国 - Wuhan Inno Pharmaceutical Technology Co., Ltd.
中国中国 - Hubei Nona Technology Co., Ltd.
中国中国 - Shanghai Taifu Pharmaceutical Technology Co., Ltd.
ドイツドイツ - Zefa-Laborservice GmbH
ドイツドイツ - MCI - Miritz Citrus Ingredients GmbH
中国中国 - Anhui Beiyike Equipment Technology Co., Ltd.

関連論文

High-performance tungsten carbide electrocatalysts for the hydrogen evolution reaction

Jing Li, Bao Wang, Wei Liu

2019-12-13 Communication

DOI: 10.1039/C9SE00853E

Catalytic depolymerization of alkali lignin in ionic liquids on Pt-supported La2O3–SO42−/ZrO2 catalysts

Xiuhui Wang, Yi Luo, Moriko Qian, Eika W. Qian

2020-01-08 Paper

DOI: 10.1039/C9SE00682F

Pulsed laser rusted stainless steel: a robust electrode material applied for energy storage and generation applications

Namachivayam Karthik, Tian Tian, Thomas Nesakumar Jebakumar Immanuel Edison, Raji Atchudan, Yong Rok Lee, Seongbeom Kim, Dangsheng Xiong

2019-12-03 Paper

DOI: 10.1039/C9SE00676A

Chemoproteomics-based target profiling of sinomenine reveals multiple protein regulators of inflammation

Lianguo Chen, Hong-jian Wang, Teng-fei Ji, Chong-Jing Zhang

2021-05-06 Communication

DOI: 10.1039/D1CC01522B

Ether-functionalization of monoethanolamine (MEA) for reversible CO2 capture under solvent-free conditions with high-capacity and low-viscosity

An-Hua Liu, Jie-Jie Li, Bai-Hao Ren, Xin-Ru Sha, He Jiang, Xiao-Bing Lu

2019-12-04 Paper

DOI: 10.1039/C9SE00756C

Retraction: Chemical synthesis and antigenic activity of a phosphatidylinositol mannoside epitope from Mycobacterium tuberculosis

Shi-Yuan Zhao, Na Li, Wan-Yue Luo, Nan-Nan Zhang, Rong-Ye Zhou, Chen-Yu Li

2021-06-06 Retraction

DOI: 10.1039/D1CC90195H

Development of wound healing scaffolds with precisely-triggered sequential release of therapeutic nanoparticles

Tauseef Ahmad, Sean McGrath, Catherine Sirafim, Ronaldo J. F. C. do Amaral, Shin-Loong Soong, Renuka Sitram, Shifa'a Turkistani, Francesco Santarella

2020-10-27 Paper

DOI: 10.1039/D0BM01277G

Synthesis and optical and electronic properties of one-dimensional sulfoxonium-based hybrid metal halide (CH3)3SOPbI3

Shiqiang Bai, Xizu Wang, Si Yin Tee, Siew Lay Lim, Lin Ke, Surani B. Dolmanan, Coryl Jing Jun Lee, Poh Chong Lim, Xiang Yao, Jishan Wu

2021-05-10 Communication

DOI: 10.1039/D1CC01386F

A new neodymium–phosphine compound for supercapacitors with long-term cycling stability

Xiaoyu Li, Huimin Chen, Chenyu Yang, Yafeng Li

2021-05-06 Communication

DOI: 10.1039/D1CC00650A